Search

everythinglearnresearchcommunity

for

Search:↓

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Personality traits and anxiety affect hair loss patients' quality of life.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Low iron levels are linked to hair loss in women.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

A liquid protein diet caused hair loss in a young woman.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Pigtail hair is a sign of new hair growth and should be recognized in hair loss conditions like acute telogen effluvium.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Monocytes might be linked to hair loss after COVID-19.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

The supplement significantly improves hair density and appearance in people with hair loss.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.